Company Encyclopedia
View More
name
Invesco S&P 100 Equal Weight ETF
EQWL.US
News
View More

Intel (INTC) Valuation Check After 88% One-Year Rally and Turnaround Momentum

Intel's stock has surged 88% over the past year, driven by its turnaround and foundry ambitions. Currently trading at $36.82, it is near analyst targets with a fair value of $37.27. However, a DCF model suggests it is overvalued at $14.71. Investors are reassessing its potential, but execution risks in AI and foundry margins remain. Simply Wall St provides tools for further analysis and investment ideas.

Simplywall·
US
INTC
+1.49%
Simplywall·
US
INTC
+1.49%

Elon Musk hits $700 billion net worth milestone after Tesla pay deal is restored

Elon Musk's net worth surpasses $700 billion after a court reinstates his Tesla pay package, originally valued at $56 billion but now worth $139 billion. The Delaware Supreme Court overturned a previous ruling, boosting Musk's wealth and reinforcing shareholder confidence in Tesla's future. Musk's fortune now exceeds Larry Page's by nearly $500 billion. SpaceX's potential IPO and recent share sale further contribute to Musk's financial milestone.

DriveTeslaCanada·
US
TSLA
-0.45%
US
TSDD
+0.95%
US
TSLL
-1.03%
DriveTeslaCanada·
US
TSLA
-0.45%
US
TSDD
+0.95%
US
TSLL
-1.03%

Pharma's $370 Billion Bet On America: The ETF Plays For 2026

In 2025, the U.S. pharmaceutical industry rebounded with a $370 billion investment pledge, driven by tariff threats and MFN pricing deals. Major firms like Eli Lilly expanded U.S. manufacturing. ETFs such as iShares U.S. Pharmaceuticals ETF offer diversified exposure to this growth. The industry is entering an investment super-cycle, with significant capital influx from major drugmakers, enhancing profitability and reinforcing the domestic drug supply chain. The Trump administration's trade policies and FDA's PreCheck program are key catalysts for this investment surge.

Talkmarkets·
US
LLY
+1.38%
Talkmarkets·
US
LLY
+1.38%

Frozen Waymos backed up San Francisco traffic during a widespread power outage

A power outage in San Francisco affected 130,000 customers and caused Waymo's driverless cars to freeze, leading to traffic jams. Social media posts showed stranded Waymo vehicles, while Teslas with FSD navigated the streets unaffected. Elon Musk tweeted that Tesla Robotaxis were not impacted by the outage.

The Verge·
US
TSLA
-0.45%
The Verge·
US
TSLA
-0.45%

Pharmaceutical Stocks To Consider - December 21st

MarketBeat's stock screener highlights seven pharmaceutical stocks to watch: Eli Lilly, Alnylam Pharmaceuticals, AbbVie, Insmed, Gilead Sciences, Vertex Pharmaceuticals, and Pfizer. These companies are noted for their high trading volumes and potential for significant returns, driven by factors like clinical trial results and regulatory approvals. Investors are advised to consider these stocks for exposure to the healthcare sector, which can offer both opportunities and volatility.

Market Beat·
US
VRTX
+1.97%
US
ABBV
+1.80%
US
LLY
+1.38%
Market Beat·
US
VRTX
+1.97%
US
ABBV
+1.80%
US
LLY
+1.38%
© 2025 Longbridge｜Disclaimer